Drug · JAK inhibitor · JAK inhibitor · Verified drug
Tofacitinib (Xeljanz) structure · mechanism
Tofacitinib (Xeljanz) 2D structure
- Role
- Drug
- Mechanism class
- JAK inhibitor
- Parent scaffold
- Pyrrolopyrimidine JAK core
- Structure source
- Catalog seed
SMILES
C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#NTags
Related compounds
External IDs · BioMoa
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.